← ANALYST RATINGS · TIPRANKS
Alpha Teknova (TKNO): analyst forecast and price target
Analyst consensus
Strong Buy6 Buy1 Hold0 Sell
Ratings of 7 analysts in the last 3 months12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $9.50, the highest $11.00, the lowest $8.00. The average is +34.2% from the last price of $7.08.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Drug Manufacturers - Specialty and GenericxAI Grok-3 | TipRanks - xAI | $8.00 → $7.50−6.2% | Hold | +5.9% | Reiterated | 16.10.26on TipRanks 03:05 | — | |
| AI DeepSeek Drug Manufacturers - Specialty and GenericDeepSeek R1-0528 | TipRanks - DeepSeek | $8.50 → $8.00−5.9% | Hold | +13.0% | Reiterated | 16.10.26on TipRanks 03:05 | — | |
| AI OpenAI Drug Manufacturers - Specialty and GenericOpenAI 4o | TipRanks - OpenAI | $8.50 → $8.00−5.9% | Hold | +13.0% | Reiterated | 16.10.26on TipRanks 03:05 | — | |
| AI Anthropic Drug Manufacturers - Specialty and GenericAnthropic Opus-4.1 | TipRanks - Anthropic | $8.50 → $7.50−11.8% | Hold | +5.9% | Reiterated | 16.10.26on TipRanks 03:05 | — | |
| AI Google Drug Manufacturers - Specialty and GenericGemini 2.5Pro | TipRanks - Google | $8.50 → $8.00−5.9% | Hold | +13.0% | Reiterated | 16.10.26on TipRanks 03:05 | — | |
| AI PerPlexity Drug Manufacturers - Specialty and GenericPerPlexity SonarPro | TipRanks - PerPlexity | $8.50 → $8.00−5.9% | Hold | +13.0% | Reiterated | 16.10.26on TipRanks 03:05 | — | |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | $7.00 → $11.00+57.1% | Buy | +55.4% | Assigned | 13.10.26on TipRanks 09:00 | −5.5%next day −4.2% | ↗ |
| Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% | William Blair | — | Buy | — | Reiterated | 30.09.26on TipRanks 08:45 | −1.8%next day −0.6% · 5 days −4.0% | ↗ |
| Max Masucci★★★★★★★★★★#2606 · hits 42% · avg +8.5% | Roth MKM | $8.00 → $10.00+25.0% | Buy | +41.2% | Reiterated | 22.09.26on TipRanks 09:10 | +5.2%next day +2.5% · 5 days +4.7% | ↗ |
| Matt Hewitt★★★★★★★★★★#3011 · hits 47% · avg +4.1% | Craig-Hallum | — | Buy | — | Reiterated | 17.09.26on TipRanks Sep 18 07:40 | +3.6%next day +4.4% · 5 days +23.8% | ↗ |
| Matthew Stanton, CFA★★★★★★★★★★#10524 · hits 43% · avg −10.9% | Jefferies | $9.00 | Buy | +27.1% | Initiated | 17.09.26on TipRanks 05:25 | +3.6%next day +4.4% · 5 days +23.8% | ↗ |
| Mark Massaro★★★★★★★★★★#2635 · hits 40% · avg +5.7% | BTIG | $8.00 | Buy | +13.0% | Upgrade | 11.08.26on TipRanks 05:55 | +5.1%next day +4.7% · 5 days −2.9% | ↗ |
| Paul Knight★★★★★★★★★★#4215 · hits 45% · avg +3.5% | KeyBanc | — | Hold | — | Reiterated | 06.08.26on TipRanks 04:16 | +16.6%next day −1.7% · 5 days +11.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Alpha Teknova
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $8.50 at a price of $8.90 (−4.5%); now: $9.50 at $7.08 (+34.2%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Buy | 4 | 4 | 3 | 6 | 8 | 9 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.07 (from $-0.09 to $-0.07). Last quarter: $-0.06.
Sales
Next quarter’s sales estimate — $12M (from $12M to $12M). Last quarter: $12M.
Best top-analyst consensus in the sector · Healthcare
About Alpha Teknova
- CEO: Stephen Gunstream
- Employees: 158
- 2290 Bert Drive, Hollister, CA, 95023, US
- www.teknova.com
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Data from the stock’s TipRanks forecast page, read 14 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗